Ascentage Pharma Group International (AAPG) Other Non-Current Assets (2023 - 2026)

Ascentage Pharma Group International's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Other Non-Current Assets fell 47.53% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $4.3 million (down 47.53% YoY), while the FY2025 annual figure was $99000.0, up 141.46% from the prior year.
• Other Non-Current Assets for Q4 2025 stood at $4.3 million, down from $13.8 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $13.8 million in Q2 2025, with the low at $22916.4 in Q4 2023.
• The 3-year median for Other Non-Current Assets is $6.3 million (2024), against an average of $6.6 million.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets surged 35926.18% in 2024, then sank 47.53% in 2025.
• Ascentage Pharma Group International's Other Non-Current Assets stood at $22916.4 in 2023, then soared by 35926.18% to $8.3 million in 2024, then tumbled by 47.53% to $4.3 million in 2025.
• Business Quant data shows AAPG's Other Non-Current Assets at $4.3 million in Q4 2025, $13.8 million in Q2 2025, and $8.3 million in Q4 2024.